Quantum AI designs custom vaccine to stop colon Cancer's return
NCT ID NCT07328087
Summary
This early study is testing a new, personalized vaccine designed by a special AI system. It is given along with standard chemotherapy and an immunotherapy drug to patients who have had surgery for stage III colon cancer. The main goal is to see if this three-part combination is safe and can teach the immune system to attack any remaining cancer cells to prevent the disease from coming back.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Biogenea Pharmaeuticals Ltd
RECRUITINGThessaloniki, 54627, Greece
Conditions
Explore the condition pages connected to this study.